geraniol has been researched along with Cancer of Skin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fatima, K; Luqman, S; Meena, A; Wani, ZA | 1 |
| Manoharan, S; Selvan, MV | 1 |
| Elson, CE; Hildebrandt, LA; Yu, SG | 1 |
3 other study(ies) available for geraniol and Cancer of Skin
| Article | Year |
|---|---|
Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells.
Topics: A549 Cells; Acyclic Monoterpenes; Carcinoma; Cell Line, Tumor; Humans; Lung Neoplasms; Molecular Docking Simulation; Skin Neoplasms | 2021 |
Chemopreventive potential of geraniol in 7,12-dimethylbenz(a) anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acyclic Monoterpenes; Animals; Antimutagenic Agents; Antineoplastic Agents; Antioxidants; Male; Mice; Skin Neoplasms; Terpenes | 2012 |
Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice.
Topics: Acyclic Monoterpenes; Animals; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Rats; Rats, Inbred BUF; Skin Neoplasms; Terpenes; Tumor Cells, Cultured | 1995 |